Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 49.45
-1.05 (-2.08%)
Sep 15, 2026, 1:40 PM CST
TPEX:6864 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.26 | 0.71 | 0.61 | 0.73 | 2.7 | 0.09 | |
Revenue Growth | 125.85% | 15.36% | -15.93% | -73.01% | 2964.77% | 20.55% |
Cost of Revenue | 1.6 | 0.38 | 0.47 | 0.4 | 1.41 | 0.04 |
Gross Profit | -0.34 | 0.33 | 0.14 | 0.33 | 1.29 | 0.05 |
Selling, General & Admin | 40.68 | 35.38 | 23.08 | 15.12 | 13.03 | 7.14 |
Research & Development | 52.17 | 60.93 | 53.54 | 45.12 | 31.63 | 21.22 |
Operating Expenses | 92.85 | 96.31 | 76.62 | 60.24 | 44.66 | 28.35 |
Operating Income | -93.19 | -95.99 | -76.48 | -59.91 | -43.37 | -28.31 |
Interest Expense | -0.43 | -0.02 | -0.03 | -0.04 | -0.08 | -0.09 |
Interest & Investment Income | 4 | 2.21 | 1.97 | 1.8 | 1.32 | 0.78 |
Other Non Operating Income (Expenses) | 0.36 | 0.2 | 0.02 | 1.36 | 2.33 | 0.31 |
Pretax Income | -89.1 | -93.6 | -74.52 | -56.79 | -39.81 | -27.31 |
Income Tax Expense | - | - | - | -5.01 | -8.07 | -4.96 |
Net Income | -89.1 | -93.6 | -74.52 | -51.78 | -31.74 | -22.35 |
Net Income to Common | -89.1 | -93.6 | -74.52 | -51.78 | -31.74 | -22.35 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 35 | 32 | 30 | 25 | 25 | 19 |
Shares Outstanding (Diluted) | 35 | 32 | 30 | 25 | 25 | 19 |
Shares Change | 8.47% | 7.29% | 21.09% | 0.10% | 32.62% | 121.58% |
EPS (Basic) | -2.54 | -2.88 | -2.46 | -2.07 | -1.27 | -1.19 |
EPS (Diluted) | -2.54 | -2.88 | -2.46 | -2.07 | -1.27 | -1.19 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -99.33 | -84.53 | -72.52 | -49.78 | -38.41 | -23.41 |
Free Cash Flow Per Share | -2.83 | -2.60 | -2.39 | -1.99 | -1.54 | -1.24 |
Gross Margin | -27.35% | 46.18% | 23.53% | 45.19% | 47.91% | 53.41% |
Operating Margin | -7407.95% | -13595.61% | -12496.24% | -8228.85% | -1608.12% | -32164.77% |
Profit Margin | -7082.35% | -13257.36% | -12175.98% | -7112.91% | -1176.75% | -25398.86% |
Free Cash Flow Margin | -7895.55% | -11973.09% | -11850.00% | -6837.78% | -1424.03% | -26606.82% |
EBITDA | -83.59 | -84.85 | -65.66 | -49.4 | -33.82 | -22.01 |
D&A For EBITDA | 9.6 | 11.13 | 10.82 | 10.51 | 9.55 | 6.29 |
EBIT | -93.19 | -95.99 | -76.48 | -59.91 | -43.37 | -28.31 |
Advertising Expenses | - | - | - | - | - | 1.12 |